185d
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
+ | |||
==SEQUENCE SPECIFICITY OF QUINOXALINE ANTIBIOTICS. 1. SOLUTION STRUCTURE OF A 1:1 COMPLEX BETWEEN TRIOSTIN A AND [D(GACGTC)]2 AND COMPARISON WITH THE SOLUTION STRUCTURE OF THE [N-MECYS3, N-MECYS7]TANDEM-[D(GATATC)]2 COMPLEX== | ==SEQUENCE SPECIFICITY OF QUINOXALINE ANTIBIOTICS. 1. SOLUTION STRUCTURE OF A 1:1 COMPLEX BETWEEN TRIOSTIN A AND [D(GACGTC)]2 AND COMPARISON WITH THE SOLUTION STRUCTURE OF THE [N-MECYS3, N-MECYS7]TANDEM-[D(GATATC)]2 COMPLEX== | ||
<StructureSection load='185d' size='340' side='right' caption='[[185d]], [[NMR_Ensembles_of_Models | 5 NMR models]]' scene=''> | <StructureSection load='185d' size='340' side='right' caption='[[185d]], [[NMR_Ensembles_of_Models | 5 NMR models]]' scene=''> | ||
Line 6: | Line 7: | ||
<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=DSN:D-SERINE'>DSN</scene>, <scene name='pdbligand=MVA:N-METHYLVALINE'>MVA</scene>, <scene name='pdbligand=NCY:N-METHYLCYSTEINE'>NCY</scene></td></tr> | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=DSN:D-SERINE'>DSN</scene>, <scene name='pdbligand=MVA:N-METHYLVALINE'>MVA</scene>, <scene name='pdbligand=NCY:N-METHYLCYSTEINE'>NCY</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[193d|193d]], [[1pfe|1pfe]], [[1vs2|1vs2]], [[1xvk|1xvk]], [[1xvn|1xvn]], [[1xvr|1xvr]], [[2adw|2adw]], [[2da8|2da8]], [[3go3|3go3]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[193d|193d]], [[1pfe|1pfe]], [[1vs2|1vs2]], [[1xvk|1xvk]], [[1xvn|1xvn]], [[1xvr|1xvr]], [[2adw|2adw]], [[2da8|2da8]], [[3go3|3go3]]</td></tr> | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=185d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=185d OCA], [http://pdbe.org/185d PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=185d RCSB], [http://www.ebi.ac.uk/pdbsum/185d PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=185d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=185d OCA], [http://pdbe.org/185d PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=185d RCSB], [http://www.ebi.ac.uk/pdbsum/185d PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=185d ProSAT]</span></td></tr> |
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> |
Revision as of 09:20, 9 August 2017
SEQUENCE SPECIFICITY OF QUINOXALINE ANTIBIOTICS. 1. SOLUTION STRUCTURE OF A 1:1 COMPLEX BETWEEN TRIOSTIN A AND [D(GACGTC)]2 AND COMPARISON WITH THE SOLUTION STRUCTURE OF THE [N-MECYS3, N-MECYS7]TANDEM-[D(GATATC)]2 COMPLEX
|